Adherence to medications for chronic conditions can improve health outcomes and reduce overall health care costs. CVS Caremark, together with Harvard Medical School and Brigham and Women's Hospital, has undertaken a multi-year research initiative focused on adherence. CVS Caremark has also analyzed medication adherence in all 50 states based on our book of business. We are sharing what we learn to help health care professionals, policy makers and patients better understand the factors that can undermine medication adherence and identify solutions to help patients take their medicines as directed.
A new study is shedding some light on the impact of gender and race on adherence to statins used to treat high cholesterol.
Leveraging a patient’s social connections and networks can play a role in improving medication adherence. That’s according to a new study by researchers at Harvard University, Brigham and Women’s Hospital and CVS Caremark.
When patients do not take their medicines as directed it is harmful to their health. CVS Caremark's Pharmacy Advisor program focuses on face-to-face counseling and pharmacist-initiated phone calls to help patients stay on their medicines for conditions like diabetes and cardiovascular disease. Not only is this good for employees, it also helps their companies reduce health care costs. It is another way we are reinventing pharmacy to help people on their path to better health.
Hear from Helena Foulkes, Chief Health Care Strategy Officer and Troyen Brennan, CMO of CVS Caremark as they talk about where medication adherence fits into health care reform and the role CVS Caremark can play as we look for innovations to encourage adherence.
Watch this video to learn more about medication adherence and the CVS Caremark report on adherence in the 50 states.
Valerie Fleishman, Executive Director of the New England Healthcare Institute discusses the organization's focus on adherence and why it matters for patients and the whole health care system. She talks about the actual cost of adherence system-wide and why it should be a national priority.
Troyen Brennan, MD, MPH, Chief Medical Officer of CVS Caremark talks about the company's research on medication adherence. He reviews the research collaboration with Harvard Medical School and Brigham and Women's Hospital,
This report shows how people in all 50 states are complying with their doctor's directions about taking medications. The report looks at adherence measures for four common chronic diseases: high blood pressure, high cholesterol, diabetes and depressions.
As a pharmacy innovation company, CVS Caremark is interested in learning why patients behave the way they do when it comes to taking, or not taking, their prescription medication.